Bio Green Med Solution (BGMS) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Bio Green Med Solution (BGMS) over the last 12 years, with Q3 2025 value amounting to 1224.69%.
- Bio Green Med Solution's EBIT Margin rose 205453100.0% to 1224.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 11324.69%, marking a year-over-year increase of 96699000.0%. This contributed to the annual value of 27916.28% for FY2024, which is 218560400.0% down from last year.
- As of Q3 2025, Bio Green Med Solution's EBIT Margin stood at 1224.69%, which was up 205453100.0% from 21770.0% recorded in Q3 2024.
- In the past 5 years, Bio Green Med Solution's EBIT Margin ranged from a high of 1224.69% in Q3 2025 and a low of 91100.0% during Q2 2024
- Its 3-year average for EBIT Margin is 27253.29%, with a median of 17290.32% in 2023.
- Data for Bio Green Med Solution's EBIT Margin shows a peak YoY increase of 210112500bps (in 2024) and a maximum YoY decrease of -895104600bps (in 2024) over the last 5 years.
- Bio Green Med Solution's EBIT Margin (Quarter) stood at 17290.32% in 2023, then dropped by -26bps to 21770.0% in 2024, then skyrocketed by 94bps to 1224.69% in 2025.
- Its EBIT Margin was 1224.69% in Q3 2025, compared to 21770.0% in Q3 2024 and 91100.0% in Q2 2024.